Hensoldt’s €1 Billion Expansion Bet Meets a Skeptical Market
Published on 04/29/2026 at 10:30 | Redaktion boerse-global.de
The gap between Hensoldt’s order intake and its production capacity has never been wider — and investors are watching closely to see whether the defence electronics group can turn a record backlog into revenue growth without sacrificing profitability.
Orders surged to €4.71 billion last year, while sales rose just under 10%, pushing the order book to an all-time high of more than €8.8 billion. That imbalance has forced management into an ambitious spending spree: roughly €1 billion earmarked for capacity expansion through 2027, including a new radar production facility, the integration of Dutch acquisition Nedinsco, and plans to hire 1,600 staff this year alone.
The cost of that ramp-up is already weighing on margins. Barclays analysts point to a parallel SAP implementation that will further drag on earnings in the near term. The market has taken note — Hensoldt shares have shed around 35% since October 2025, and the stock now trades about 4% below its 50-day moving average and 12% below the 200-day line.
A China Shock That Faded Quickly
Geopolitics added to the pressure last week when Beijing placed Hensoldt on an export control list, triggering a double-digit drop in the share price within seven trading days. The sell-off eased after Taiwan’s Defence Minister Wellington Koo clarified that the sanctions would not affect the island’s defence procurement. The stock recovered modestly, closing at €72.40 on Tuesday.
Should investors sell immediately? Or is it worth buying Hensoldt?
JPMorgan analyst David Perry sees the broader correction as an opportunity. In a note published Wednesday, he maintained a “Neutral” rating but lifted the price target to €85, implying roughly 14% upside from the current level of €74.38. The pullback in German defence stocks since autumn 2025 has brought valuations back into line with growth prospects, Perry argues, adding that while ceasefire scenarios and the rise of drone warfare pose real questions about future defence doctrines, those risks appear overblown in the current environment.
Structural Tailwinds vs. Operational Reality
The macro backdrop remains supportive. The German government has signed defence contracts worth €111 billion since 2022, and the country’s 2027 defence budget could rise by around 21%. French rival Thales reported a 75% jump in defence orders for the first quarter, underscoring the sector’s momentum.
Hensoldt itself is targeting 2026 revenue of roughly €2.75 billion with an adjusted EBITDA margin between 18.5% and 19%. But the path to those numbers runs through a series of near-term hurdles.
The first test comes on May 6, when the company publishes first-quarter results. Analysts expect quarterly sales of around €493 million and, due to typical seasonality, a negative earnings per share of minus €0.16. The numbers will provide an early reality check on whether annual targets remain achievable and whether order momentum is accelerating.
Divergent Analyst Views and a Dividend Decision
The Street is split on valuation. Deutsche Bank sees the stock reaching €101, citing solid operational performance. Barclays is more cautious with an “Equal Weight” rating and a €95 target. JPMorgan’s €85 sits at the lower end, reflecting Perry’s neutral stance.
Hensoldt at a turning point? This analysis reveals what investors need to know now.
Shareholders will have another item to focus on at the annual general meeting on May 22. Management has proposed a dividend of €0.55 per share, a 10% increase from last year, with the ex-dividend date set for May 25.
Until then, the stock remains under pressure. The Q1 figures will show whether Hensoldt’s operational momentum can justify Perry’s optimism — or whether the costly capacity expansion is about to test investor patience.
Ad
Hensoldt Stock: New Analysis - 29 April
Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
